Rank | Gene Set | Z-score |
---|---|---|
1 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.26132794 |
2 | * negative regulation of cell killing (GO:0031342) | 6.21404307 |
3 | * negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.21404307 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.01933160 |
5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.68873349 |
6 | * antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.68873349 |
7 | * antigen processing and presentation of endogenous antigen (GO:0019883) | 5.55329167 |
8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.95950471 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.89922019 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.89922019 |
11 | modulation by symbiont of host immune response (GO:0052553) | 4.89922019 |
12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.89922019 |
13 | modulation by symbiont of host defense response (GO:0052031) | 4.89922019 |
14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.89922019 |
15 | detection of other organism (GO:0098543) | 4.70791475 |
16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.64165915 |
17 | neutrophil activation involved in immune response (GO:0002283) | 4.62341297 |
18 | detection of bacterium (GO:0016045) | 4.61679579 |
19 | regulation of gamma-delta T cell activation (GO:0046643) | 4.51084388 |
20 | macrophage activation involved in immune response (GO:0002281) | 4.33985023 |
21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.23892426 |
22 | response to interleukin-15 (GO:0070672) | 4.21534805 |
23 | leukocyte aggregation (GO:0070486) | 4.20205531 |
24 | immunoglobulin mediated immune response (GO:0016064) | 3.99922730 |
25 | cellular response to interleukin-15 (GO:0071350) | 3.97310499 |
26 | negative thymic T cell selection (GO:0045060) | 3.92120187 |
27 | negative T cell selection (GO:0043383) | 3.90937743 |
28 | negative regulation of interleukin-12 production (GO:0032695) | 3.89951380 |
29 | * negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.89469166 |
30 | detection of external biotic stimulus (GO:0098581) | 3.88458878 |
31 | response to peptidoglycan (GO:0032494) | 3.81891483 |
32 | cellular extravasation (GO:0045123) | 3.74991915 |
33 | neutrophil activation (GO:0042119) | 3.71447507 |
34 | positive thymic T cell selection (GO:0045059) | 3.71114271 |
35 | negative regulation of T cell mediated immunity (GO:0002710) | 3.68586565 |
36 | * type I interferon signaling pathway (GO:0060337) | 3.66640416 |
37 | * cellular response to type I interferon (GO:0071357) | 3.66640416 |
38 | * response to type I interferon (GO:0034340) | 3.64839624 |
39 | regulation of T cell tolerance induction (GO:0002664) | 3.64633424 |
40 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.60540822 |
41 | * negative regulation of leukocyte mediated immunity (GO:0002704) | 3.55617067 |
42 | microglial cell activation (GO:0001774) | 3.53314991 |
43 | B cell receptor signaling pathway (GO:0050853) | 3.51170267 |
44 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.46235818 |
45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.43567576 |
46 | response to host immune response (GO:0052572) | 3.43567576 |
47 | granulocyte activation (GO:0036230) | 3.43545499 |
48 | myeloid cell activation involved in immune response (GO:0002275) | 3.43537101 |
49 | regulation of tolerance induction (GO:0002643) | 3.42710477 |
50 | respiratory burst (GO:0045730) | 3.40954203 |
51 | detection of molecule of bacterial origin (GO:0032490) | 3.40394663 |
52 | detection of biotic stimulus (GO:0009595) | 3.39651441 |
53 | regulation of B cell differentiation (GO:0045577) | 3.34793386 |
54 | tolerance induction (GO:0002507) | 3.32727725 |
55 | positive regulation of B cell differentiation (GO:0045579) | 3.32715535 |
56 | regulation of regulatory T cell differentiation (GO:0045589) | 3.31716630 |
57 | T cell migration (GO:0072678) | 3.30723438 |
58 | regulation of mast cell degranulation (GO:0043304) | 3.29526587 |
59 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.28466533 |
60 | positive T cell selection (GO:0043368) | 3.27926386 |
61 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.26759522 |
62 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.26116221 |
63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.25897779 |
64 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.24672279 |
65 | T cell selection (GO:0045058) | 3.24102182 |
66 | * regulation of T cell mediated cytotoxicity (GO:0001914) | 3.21381663 |
67 | B cell mediated immunity (GO:0019724) | 3.18894627 |
68 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.18857545 |
69 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.18605628 |
70 | response to host (GO:0075136) | 3.18605628 |
71 | response to host defenses (GO:0052200) | 3.18605628 |
72 | thymic T cell selection (GO:0045061) | 3.18260952 |
73 | defense response to protozoan (GO:0042832) | 3.16082705 |
74 | macrophage activation (GO:0042116) | 3.15419712 |
75 | positive regulation of mast cell activation (GO:0033005) | 3.09598079 |
76 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.08545267 |
77 | * positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.08350557 |
78 | response to muramyl dipeptide (GO:0032495) | 3.07939983 |
79 | * regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.05465248 |
80 | * regulation of natural killer cell mediated immunity (GO:0002715) | 3.05465248 |
81 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.02028543 |
82 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.01824066 |
83 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.01824066 |
84 | germinal center formation (GO:0002467) | 3.01141547 |
85 | regulation of antigen processing and presentation (GO:0002577) | 3.00944229 |
86 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00779490 |
87 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.00479630 |
88 | leukocyte degranulation (GO:0043299) | 2.98542507 |
89 | positive regulation of tolerance induction (GO:0002645) | 2.98004286 |
90 | activated T cell proliferation (GO:0050798) | 2.96876932 |
91 | negative regulation of phagocytosis (GO:0050765) | 2.96148848 |
92 | dendritic cell chemotaxis (GO:0002407) | 2.95548612 |
93 | regulation of mast cell activation (GO:0033003) | 2.92831640 |
94 | positive regulation of antigen processing and presentation (GO:0002579) | 2.88753620 |
95 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.88505077 |
96 | neutrophil mediated immunity (GO:0002446) | 2.87466836 |
97 | regulation of leukocyte degranulation (GO:0043300) | 2.87413744 |
98 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.85363828 |
99 | dendritic cell migration (GO:0036336) | 2.84153370 |
100 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.84040049 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.88851331 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.52578769 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.30086381 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.03582970 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.91756422 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.55529522 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.49815808 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01610699 |
9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.94599053 |
10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.91800467 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.88415901 |
12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.68024983 |
13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61216051 |
14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.57918333 |
15 | MYB_26560356_Chip-Seq_TH2_Human | 2.48015522 |
16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.45636394 |
17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.45004078 |
18 | MAF_26560356_Chip-Seq_TH1_Human | 2.40905961 |
19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.38395515 |
20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.38074436 |
21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36596147 |
22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.35206366 |
23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.32678258 |
24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.30908570 |
25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.29746707 |
26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.24274889 |
27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.15086757 |
28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.13404910 |
29 | MYB_26560356_Chip-Seq_TH1_Human | 2.09369879 |
30 | MYC_22102868_ChIP-Seq_BL_Human | 2.06393058 |
31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03094345 |
32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99591816 |
33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.95602217 |
34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94851476 |
35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83844923 |
36 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.82169161 |
37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80915324 |
38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.77223921 |
39 | MAF_26560356_Chip-Seq_TH2_Human | 1.76889858 |
40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.73087409 |
41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.72817305 |
42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70329132 |
43 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68607220 |
44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.58932955 |
45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58363888 |
46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55330309 |
47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55285889 |
48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.53490947 |
49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.51887840 |
50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45394421 |
51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43811501 |
52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41333276 |
53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40327928 |
54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39326783 |
55 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38656564 |
56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37002360 |
57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.35923795 |
58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34771665 |
59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33100910 |
60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30787542 |
61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29454413 |
62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27717917 |
63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26655296 |
64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25618393 |
65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25314338 |
66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23451007 |
67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22941777 |
68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22105113 |
69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21690486 |
70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21272584 |
71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19565788 |
72 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.18470286 |
73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18032508 |
74 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17430578 |
75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15627419 |
76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14163299 |
77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14013057 |
78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13101370 |
79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12843497 |
80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12685231 |
81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11030364 |
82 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09261450 |
83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06607346 |
84 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04748911 |
85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04524648 |
86 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03777519 |
87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00660308 |
88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96855492 |
89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94836728 |
90 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.94546949 |
91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92949599 |
92 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92149550 |
93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90309448 |
94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89852972 |
95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87431588 |
96 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.85032802 |
97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83052626 |
98 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82567989 |
99 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81235472 |
100 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80314780 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.66947541 |
2 | MP0003436_decreased_susceptibility_to | 3.99655676 |
3 | MP0001835_abnormal_antigen_presentation | 3.86138278 |
4 | MP0005671_abnormal_response_to | 3.50347162 |
5 | MP0003303_peritoneal_inflammation | 3.45905122 |
6 | MP0001800_abnormal_humoral_immune | 3.03595210 |
7 | MP0005000_abnormal_immune_tolerance | 3.00159159 |
8 | MP0006082_CNS_inflammation | 2.99135505 |
9 | MP0005387_immune_system_phenotype | 2.93409427 |
10 | MP0001790_abnormal_immune_system | 2.93409427 |
11 | MP0000685_abnormal_immune_system | 2.92950612 |
12 | MP0002419_abnormal_innate_immunity | 2.92087425 |
13 | MP0009785_altered_susceptibility_to | 2.90667580 |
14 | MP0005025_abnormal_response_to | 2.88383007 |
15 | MP0003763_abnormal_thymus_physiology | 2.78601099 |
16 | MP0002723_abnormal_immune_serum | 2.67760964 |
17 | MP0002452_abnormal_antigen_presenting | 2.57990204 |
18 | MP0002420_abnormal_adaptive_immunity | 2.57767930 |
19 | MP0001819_abnormal_immune_cell | 2.55090547 |
20 | MP0003300_gastrointestinal_ulcer | 2.50988902 |
21 | MP0002148_abnormal_hypersensitivity_rea | 2.40522868 |
22 | MP0005464_abnormal_platelet_physiology | 2.29672342 |
23 | MP0002405_respiratory_system_inflammati | 2.10440156 |
24 | MP0001533_abnormal_skeleton_physiology | 2.09308299 |
25 | MP0010155_abnormal_intestine_physiology | 2.08568058 |
26 | MP0003191_abnormal_cellular_cholesterol | 2.01376202 |
27 | MP0002398_abnormal_bone_marrow | 1.98700161 |
28 | MP0000716_abnormal_immune_system | 1.94889873 |
29 | MP0009333_abnormal_splenocyte_physiolog | 1.94508870 |
30 | MP0004947_skin_inflammation | 1.85132129 |
31 | MP0000465_gastrointestinal_hemorrhage | 1.82975551 |
32 | MP0001845_abnormal_inflammatory_respons | 1.81797880 |
33 | MP0003866_abnormal_defecation | 1.75965288 |
34 | MP0000689_abnormal_spleen_morphology | 1.64612779 |
35 | MP0002132_abnormal_respiratory_system | 1.63672438 |
36 | MP0002722_abnormal_immune_system | 1.60783005 |
37 | MP0008260_abnormal_autophagy | 1.58154858 |
38 | MP0002429_abnormal_blood_cell | 1.53957575 |
39 | MP0003828_pulmonary_edema | 1.53887533 |
40 | MP0003172_abnormal_lysosome_physiology | 1.52032777 |
41 | MP0000703_abnormal_thymus_morphology | 1.50305004 |
42 | MP0005310_abnormal_salivary_gland | 1.47755510 |
43 | MP0008469_abnormal_protein_level | 1.46481388 |
44 | MP0000858_altered_metastatic_potential | 1.41277900 |
45 | MP0009764_decreased_sensitivity_to | 1.40221315 |
46 | MP0009278_abnormal_bone_marrow | 1.39283698 |
47 | MP0001873_stomach_inflammation | 1.39211680 |
48 | MP0001851_eye_inflammation | 1.38696734 |
49 | MP0004381_abnormal_hair_follicle | 1.35175249 |
50 | MP0003183_abnormal_peptide_metabolism | 1.33636879 |
51 | MP0002998_abnormal_bone_remodeling | 1.29085817 |
52 | MP0002166_altered_tumor_susceptibility | 1.28428746 |
53 | MP0004883_abnormal_blood_vessel | 1.27116319 |
54 | MP0004510_myositis | 1.26069001 |
55 | MP0003075_altered_response_to | 1.22478342 |
56 | MP0002396_abnormal_hematopoietic_system | 1.22260425 |
57 | MP0005058_abnormal_lysosome_morphology | 1.17943321 |
58 | MP0005451_abnormal_body_composition | 1.17517017 |
59 | MP0002277_abnormal_respiratory_mucosa | 1.15457581 |
60 | MP0003690_abnormal_glial_cell | 1.15380522 |
61 | MP0005166_decreased_susceptibility_to | 1.10474216 |
62 | MP0001545_abnormal_hematopoietic_system | 1.09446486 |
63 | MP0005397_hematopoietic_system_phenotyp | 1.09446486 |
64 | MP0005164_abnormal_response_to | 1.04165229 |
65 | MP0002138_abnormal_hepatobiliary_system | 1.03554157 |
66 | MP0008004_abnormal_stomach_pH | 1.03516743 |
67 | MP0002933_joint_inflammation | 1.01747467 |
68 | MP0003448_altered_tumor_morphology | 1.00073889 |
69 | MP0001853_heart_inflammation | 0.96829518 |
70 | MP0001663_abnormal_digestive_system | 0.96796351 |
71 | MP0000343_altered_response_to | 0.96350035 |
72 | MP0009763_increased_sensitivity_to | 0.93993293 |
73 | MP0000604_amyloidosis | 0.88189597 |
74 | MP0005390_skeleton_phenotype | 0.86331491 |
75 | MP0003045_fibrosis | 0.83850346 |
76 | MP0005075_abnormal_melanosome_morpholog | 0.82534055 |
77 | MP0000249_abnormal_blood_vessel | 0.82132792 |
78 | MP0002006_tumorigenesis | 0.81182309 |
79 | MP0009840_abnormal_foam_cell | 0.76322528 |
80 | MP0000490_abnormal_crypts_of | 0.72689318 |
81 | MP0002254_reproductive_system_inflammat | 0.72026771 |
82 | MP0004808_abnormal_hematopoietic_stem | 0.68405485 |
83 | MP0009765_abnormal_xenobiotic_induced | 0.67452980 |
84 | MP0003795_abnormal_bone_structure | 0.66504490 |
85 | MP0003091_abnormal_cell_migration | 0.65347022 |
86 | MP0008874_decreased_physiological_sensi | 0.65250835 |
87 | MP0004130_abnormal_muscle_cell | 0.64033422 |
88 | MP0003806_abnormal_nucleotide_metabolis | 0.61691168 |
89 | MP0000015_abnormal_ear_pigmentation | 0.59736168 |
90 | MP0005167_abnormal_blood-brain_barrier | 0.56864438 |
91 | MP0001958_emphysema | 0.55781617 |
92 | MP0001986_abnormal_taste_sensitivity | 0.55611235 |
93 | MP0003656_abnormal_erythrocyte_physiolo | 0.55523796 |
94 | MP0005381_digestive/alimentary_phenotyp | 0.54747264 |
95 | MP0002693_abnormal_pancreas_physiology | 0.49673755 |
96 | MP0002019_abnormal_tumor_incidence | 0.49169283 |
97 | MP0002332_abnormal_exercise_endurance | 0.48329150 |
98 | MP0000609_abnormal_liver_physiology | 0.46643125 |
99 | MP0000920_abnormal_myelination | 0.46486877 |
100 | MP0001348_abnormal_lacrimal_gland | 0.46109980 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.35378998 |
2 | Myositis (HP:0100614) | 5.57340447 |
3 | Recurrent abscess formation (HP:0002722) | 5.38475409 |
4 | Recurrent bacterial skin infections (HP:0005406) | 5.31772530 |
5 | Orchitis (HP:0100796) | 5.15921103 |
6 | Abnormality of macrophages (HP:0004311) | 5.02360602 |
7 | Optic neuritis (HP:0100653) | 4.93702764 |
8 | Retrobulbar optic neuritis (HP:0100654) | 4.93702764 |
9 | Stomatitis (HP:0010280) | 4.77670787 |
10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.75311492 |
11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.30824512 |
12 | Recurrent fungal infections (HP:0002841) | 4.19134388 |
13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.08329656 |
14 | Mediastinal lymphadenopathy (HP:0100721) | 4.00792449 |
15 | Gastrointestinal infarctions (HP:0005244) | 4.00468781 |
16 | Meningitis (HP:0001287) | 4.00123591 |
17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.81171143 |
18 | Obstructive lung disease (HP:0006536) | 3.81171143 |
19 | T lymphocytopenia (HP:0005403) | 3.77579975 |
20 | Spontaneous hematomas (HP:0007420) | 3.71122482 |
21 | Encephalitis (HP:0002383) | 3.70656790 |
22 | Abnormality of T cell number (HP:0011839) | 3.69565058 |
23 | Recurrent skin infections (HP:0001581) | 3.68797323 |
24 | Vasculitis (HP:0002633) | 3.64243755 |
25 | Keratoconjunctivitis sicca (HP:0001097) | 3.63976028 |
26 | Prolonged bleeding time (HP:0003010) | 3.59531812 |
27 | Increased IgE level (HP:0003212) | 3.58173604 |
28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.54562688 |
29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.54562688 |
30 | Keratoconjunctivitis (HP:0001096) | 3.53376498 |
31 | Pulmonary infiltrates (HP:0002113) | 3.23133749 |
32 | Gingivitis (HP:0000230) | 3.22864275 |
33 | Chest pain (HP:0100749) | 3.17321569 |
34 | Urticaria (HP:0001025) | 3.12718617 |
35 | Abnormality of T cells (HP:0002843) | 3.11975582 |
36 | Pustule (HP:0200039) | 3.10450017 |
37 | Cellulitis (HP:0100658) | 3.05231849 |
38 | Hemoptysis (HP:0002105) | 3.04714963 |
39 | Epistaxis (HP:0000421) | 3.02810296 |
40 | Recurrent viral infections (HP:0004429) | 3.02359688 |
41 | Gingival bleeding (HP:0000225) | 3.02173978 |
42 | Increased IgM level (HP:0003496) | 3.00892653 |
43 | Leukocytosis (HP:0001974) | 2.94619384 |
44 | Inflammation of the large intestine (HP:0002037) | 2.94049024 |
45 | Panhypogammaglobulinemia (HP:0003139) | 2.91912370 |
46 | Gastrointestinal inflammation (HP:0004386) | 2.83834707 |
47 | Petechiae (HP:0000967) | 2.83173519 |
48 | Arterial thrombosis (HP:0004420) | 2.82256518 |
49 | Granulocytopenia (HP:0001913) | 2.73690886 |
50 | Pulmonary embolism (HP:0002204) | 2.69423423 |
51 | Recurrent bronchitis (HP:0002837) | 2.61786462 |
52 | Purpura (HP:0000979) | 2.61768057 |
53 | Agammaglobulinemia (HP:0004432) | 2.61733538 |
54 | Episodic fever (HP:0001954) | 2.58090482 |
55 | Lymphopenia (HP:0001888) | 2.57155872 |
56 | Hypochromic anemia (HP:0001931) | 2.56800897 |
57 | Abnormality of T cell physiology (HP:0011840) | 2.56095080 |
58 | Anorexia (HP:0002039) | 2.54796421 |
59 | Hypergammaglobulinemia (HP:0010702) | 2.53884972 |
60 | Colitis (HP:0002583) | 2.53143134 |
61 | Autoimmune hemolytic anemia (HP:0001890) | 2.49197221 |
62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.46785146 |
63 | Eosinophilia (HP:0001880) | 2.44417733 |
64 | Gangrene (HP:0100758) | 2.41448283 |
65 | Abnormality of the pleura (HP:0002103) | 2.37750382 |
66 | Osteomyelitis (HP:0002754) | 2.36142922 |
67 | Hypochromic microcytic anemia (HP:0004840) | 2.33976979 |
68 | Chronic otitis media (HP:0000389) | 2.28216239 |
69 | Autoimmune thrombocytopenia (HP:0001973) | 2.27285215 |
70 | Nasal polyposis (HP:0100582) | 2.25419200 |
71 | Gastrointestinal stroma tumor (HP:0100723) | 2.23868715 |
72 | Sepsis (HP:0100806) | 2.23803622 |
73 | Peritonitis (HP:0002586) | 2.23453833 |
74 | IgM deficiency (HP:0002850) | 2.23071549 |
75 | Amyloidosis (HP:0011034) | 2.22407526 |
76 | Abnormality of eosinophils (HP:0001879) | 2.20209345 |
77 | Joint swelling (HP:0001386) | 2.14677242 |
78 | Glomerulopathy (HP:0100820) | 2.14592865 |
79 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14016180 |
80 | Abnormal platelet volume (HP:0011876) | 2.13586453 |
81 | Abnormality of the nasal mucosa (HP:0000433) | 2.11693159 |
82 | Chronic diarrhea (HP:0002028) | 2.10021157 |
83 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08498302 |
84 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08498302 |
85 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08498302 |
86 | IgG deficiency (HP:0004315) | 2.06507199 |
87 | Skin ulcer (HP:0200042) | 2.05791223 |
88 | Abnormality of the peritoneum (HP:0002585) | 2.04137862 |
89 | Systemic lupus erythematosus (HP:0002725) | 2.04093301 |
90 | Vertigo (HP:0002321) | 2.03752832 |
91 | Interstitial pulmonary disease (HP:0006530) | 2.02806699 |
92 | Increased cerebral lipofuscin (HP:0011813) | 2.02757556 |
93 | Microcytic anemia (HP:0001935) | 2.00827882 |
94 | Hepatosplenomegaly (HP:0001433) | 2.00468951 |
95 | Loss of speech (HP:0002371) | 2.00078920 |
96 | Increased serum ferritin (HP:0003281) | 1.99608487 |
97 | Keratitis (HP:0000491) | 1.98922246 |
98 | Verrucae (HP:0200043) | 1.97346950 |
99 | Papilloma (HP:0012740) | 1.97346950 |
100 | Acne (HP:0001061) | 1.96833400 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.31749493 |
2 | MAP4K1 | 4.05523667 |
3 | TYK2 | 2.82577993 |
4 | BLK | 2.78537865 |
5 | TXK | 2.65686167 |
6 | CSK | 2.64920074 |
7 | ERN1 | 2.63686139 |
8 | FES | 2.62529987 |
9 | IRAK4 | 2.60172863 |
10 | MAP2K3 | 2.33890993 |
11 | GRK6 | 2.26947433 |
12 | ZAP70 | 2.26547456 |
13 | PRPF4B | 2.19854877 |
14 | MAP3K14 | 2.06070316 |
15 | MAP3K13 | 2.03675990 |
16 | BTK | 2.02942938 |
17 | JAK3 | 2.01423812 |
18 | TNK2 | 1.99830861 |
19 | EPHB1 | 1.92704921 |
20 | TAOK3 | 1.87702621 |
21 | IKBKE | 1.86222271 |
22 | SYK | 1.83388017 |
23 | JAK1 | 1.72499652 |
24 | TBK1 | 1.70507080 |
25 | HCK | 1.68828849 |
26 | FGR | 1.62549500 |
27 | MAP3K3 | 1.60068079 |
28 | ITK | 1.57790750 |
29 | MAP3K11 | 1.49721735 |
30 | LYN | 1.41611446 |
31 | TAOK1 | 1.39101145 |
32 | LCK | 1.36314191 |
33 | CSF1R | 1.34359462 |
34 | JAK2 | 1.29929539 |
35 | SIK3 | 1.26117547 |
36 | KIT | 1.25801154 |
37 | IKBKB | 1.19254704 |
38 | TEC | 1.19087650 |
39 | MAP3K1 | 1.16460328 |
40 | TESK2 | 1.09870914 |
41 | FGFR4 | 1.01237635 |
42 | MARK3 | 1.00788872 |
43 | BMPR2 | 0.99405863 |
44 | TGFBR2 | 0.96820760 |
45 | STK10 | 0.95326283 |
46 | MATK | 0.93650678 |
47 | KSR2 | 0.86989386 |
48 | PDK1 | 0.86245242 |
49 | TAOK2 | 0.84976111 |
50 | IRAK1 | 0.84788605 |
51 | TRIB3 | 0.81381108 |
52 | MARK2 | 0.80655884 |
53 | EPHA3 | 0.77646518 |
54 | FGFR3 | 0.77595472 |
55 | SIK2 | 0.77078482 |
56 | PTK6 | 0.75649780 |
57 | PRKCQ | 0.74585922 |
58 | CDC42BPA | 0.74524746 |
59 | PRKD2 | 0.74088115 |
60 | YES1 | 0.73073508 |
61 | MAP3K7 | 0.71444327 |
62 | FYN | 0.70297933 |
63 | MAPK12 | 0.70011487 |
64 | PDPK1 | 0.68371057 |
65 | NLK | 0.66484652 |
66 | LRRK2 | 0.66266323 |
67 | CAMKK1 | 0.66199243 |
68 | MAPK7 | 0.66075683 |
69 | HIPK2 | 0.63116718 |
70 | GRK7 | 0.62122241 |
71 | PTK2B | 0.61627457 |
72 | PIK3CG | 0.56254995 |
73 | SMG1 | 0.55290125 |
74 | PIM1 | 0.55230517 |
75 | KDR | 0.54187966 |
76 | CAMKK2 | 0.53361334 |
77 | MAP3K6 | 0.52931680 |
78 | SIK1 | 0.52137983 |
79 | IRAK2 | 0.51053220 |
80 | MAP2K6 | 0.48391365 |
81 | DYRK1B | 0.44487775 |
82 | MAP3K5 | 0.44407385 |
83 | RIPK1 | 0.41944888 |
84 | RET | 0.39250211 |
85 | MAPKAPK2 | 0.38757613 |
86 | MAPK11 | 0.36988211 |
87 | MAP3K2 | 0.36616749 |
88 | RPS6KL1 | 0.35549262 |
89 | RPS6KC1 | 0.35549262 |
90 | MAP2K2 | 0.35265334 |
91 | STK38 | 0.34166237 |
92 | PASK | 0.33594917 |
93 | SGK3 | 0.33478500 |
94 | STK11 | 0.33180051 |
95 | BMX | 0.32744794 |
96 | RAF1 | 0.30000719 |
97 | CHUK | 0.29886872 |
98 | RPS6KA6 | 0.29842446 |
99 | CDK19 | 0.29481691 |
100 | PRKD1 | 0.28070671 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 2.88004543 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.86717358 |
3 | * Allograft rejection_Homo sapiens_hsa05330 | 2.81978722 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.80946259 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.77454983 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.72148014 |
7 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.65177424 |
8 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.36024532 |
9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.27901802 |
10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.27543463 |
11 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.02441161 |
12 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 1.97486825 |
13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93565713 |
14 | Tuberculosis_Homo sapiens_hsa05152 | 1.93557447 |
15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.93216415 |
16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.89069972 |
17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.87261096 |
18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.85899685 |
19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83131885 |
20 | Measles_Homo sapiens_hsa05162 | 1.81371179 |
21 | Malaria_Homo sapiens_hsa05144 | 1.76926104 |
22 | Asthma_Homo sapiens_hsa05310 | 1.76920977 |
23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.73111173 |
24 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.68207563 |
25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.61907286 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57949120 |
27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.56711631 |
28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.53446420 |
29 | Influenza A_Homo sapiens_hsa05164 | 1.50468775 |
30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.50108742 |
31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42352042 |
32 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.40088934 |
33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33782506 |
34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29712852 |
35 | Legionellosis_Homo sapiens_hsa05134 | 1.27493780 |
36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25603466 |
37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.25278870 |
38 | Platelet activation_Homo sapiens_hsa04611 | 1.22800661 |
39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21822568 |
40 | * Phagosome_Homo sapiens_hsa04145 | 1.18962945 |
41 | Pertussis_Homo sapiens_hsa05133 | 1.13494700 |
42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.11622004 |
43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10220485 |
44 | Hepatitis C_Homo sapiens_hsa05160 | 1.08326077 |
45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06190602 |
46 | Hepatitis B_Homo sapiens_hsa05161 | 1.05552186 |
47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00805909 |
48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00145194 |
49 | Apoptosis_Homo sapiens_hsa04210 | 0.96324973 |
50 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95123400 |
51 | Shigellosis_Homo sapiens_hsa05131 | 0.93443257 |
52 | Salmonella infection_Homo sapiens_hsa05132 | 0.90020456 |
53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86215529 |
54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83867505 |
55 | Lysosome_Homo sapiens_hsa04142 | 0.79381944 |
56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76643573 |
57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75069771 |
58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73050762 |
59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71599819 |
60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68608383 |
61 | * Endocytosis_Homo sapiens_hsa04144 | 0.67864743 |
62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66235811 |
63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65615906 |
64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64414601 |
65 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63975846 |
66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60313316 |
67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59709415 |
68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59309842 |
69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56905637 |
70 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.55772373 |
71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55585867 |
72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55452856 |
73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53873410 |
74 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53832177 |
75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52818466 |
76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52035031 |
77 | Amoebiasis_Homo sapiens_hsa05146 | 0.49963249 |
78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49856158 |
79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46306951 |
80 | Insulin resistance_Homo sapiens_hsa04931 | 0.45897216 |
81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45375314 |
82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45174807 |
83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44788425 |
84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43526839 |
85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43030079 |
86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41735704 |
87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41168838 |
88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39407739 |
89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38735503 |
90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37931403 |
91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37889900 |
92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37526402 |
93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34807242 |
94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34337224 |
95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33273524 |
96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31985986 |
97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29916709 |
98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29131270 |
99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28566695 |
100 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.28360402 |